Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 5Phase 1/2 2Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 151Lung Neoplasms 34Carcinoma 11Parkinson Disease 4, Autosomal Dominant Lewy Body 10Neoplasms 9Neoplasm Metastasis 9Mesothelioma 5Adenocarcinoma of Lung 5Uterine Cervical Neoplasms 4Thoracic Neoplasms 4Respiratory Tract Neoplasms 4Respiratory Tract Diseases 4Mesothelioma, Malignant 4Lung Diseases 4Carcinoma, Bronchogenic 4Non-squamous Non-small Cell Lung Cancer 3Non-Squamous Non-Small Cell Lung Cancer 3Neoplasms by Site 3NSCLC 3Bronchial Neoplasms 3Adenocarcinoma 3Recurrence 2Non-Squamous Non-small Cell Lung Cancer 2Non Small Cell Lung Carcinoma NSCLC 2Head and Neck Neoplasms 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1

Interventions

Etoposide 34Carboplatin 31Topotecan 24Cisplatin 21atezolizumab 11PM 01183 8durvalumab 7Irinotecan 7amrubicin 5PE regimen 4AMG 757 4rovalpituzumab tesirine 3pembrolizumab 3Magnetic Resonance Spectroscopy 3Dexamethasone 3tremelimumab 2tislelizumab 2etoposide phosphate 2apatinib 2Vitamin E 2Tiragolumab 2Specimen Handling 2Radiosurgery 2RRx-001 2Paclitaxel 2Memantine 2Injections 2EC regimen 2trilaciclib 1toripalimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Small Cell Lung Carcinoma × Pemetrexed × Clear all
NCT00363415 2009-10-28

Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer

Eli Lilly and Company

Phase 3 Completed
908 enrolled 15 charts
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡